Ropes Wealth Advisors LLC Abbott Laboratories Transaction History

Ropes Wealth Advisors LLC

$512 Million
Q3 2023

A detailed history of Ropes Wealth Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 34,019 shares of ABT stock, worth $4.01 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

34,019

Previous 37,178 8.5%

Holding current value

$4.01 Million

Previous $4.05 Million 18.73%

% of portfolio

0.64%

Previous 0.68%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $301,779 - $362,084	-3,159 Reduced 8.5%	34,019 $3.29 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $300,828 - $335,185	2,985 Added 8.73%	37,178 $4.05 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $181,031 - $213,084	1,869 Added 5.78%	34,193 $3.46 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $65,401 - $76,725	688 Added 2.17%	32,324 $3.55 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $343,981 - $398,266	3,555 Added 12.66%	31,636 $3.06 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $36,847 - $44,536	361 Added 1.3%	28,081 $3.05 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $175,818 - $214,399	-1,542 Reduced 5.27%	27,720 $3.28 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $1.61 Million - $1.98 Million	-13,967 Reduced 32.31%	29,262 $4.12 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $151,308 - $167,390	-1,297 Reduced 2.91%	43,229 $5.11 Million
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $207,348 - $244,078	1,960 Added 4.6%	44,526 $5.16 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $606,565 - $714,625	5,573 Added 15.07%	42,566 $5.04 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $166,005 - $180,898	-1,581 Reduced 4.1%	36,993 $4.05 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $265,206 - $322,073	-2,894 Reduced 6.98%	38,574 $4.2 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $64,931 - $83,104	-848 Reduced 2.0%	41,468 $3.79 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $54,402 - $79,550	866 Added 2.09%	42,316 $3.34 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $253,979 - $282,739	-3,235 Reduced 7.24%	41,450 $3.6 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $256,159 - $277,756	-3,130 Reduced 6.55%	44,685 $3.74 Million
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $672,682 - $784,550	9,230 Added 23.92%	47,815 $4.02 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $169,390 - $204,793	-2,558 Reduced 6.22%	38,585 $3.08 Million
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $32,517 - $36,837	496 Added 1.22%	41,143 $2.98 Million
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $288,847 - $348,460	4,750 Added 13.23%	40,647 $2.98 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $16,292 - $17,981	283 Added 0.79%	35,897 $2.19 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $130,433 - $147,471	-2,318 Reduced 6.11%	35,614 $2.13 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $229,159 - $245,339	4,269 Added 12.68%	37,932 $2.17 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $1.62 Million - $1.81 Million	33,663	33,663 $1.8 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.

Account

Ropes Wealth Advisors LLC Abbott Laboratories Transaction History